Economic Dimensions of Personalized and Precision Medicine
eBook - ePub

Economic Dimensions of Personalized and Precision Medicine

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Economic Dimensions of Personalized and Precision Medicine

About this book

Personalized and precision medicine (PPM)—the targeting of therapies according to an individual's genetic, environmental, or lifestyle characteristics—is becoming an increasingly important approach in health care treatment and prevention. The advancement of PPM is a challenge in traditional clinical, reimbursement, and regulatory landscapes because it is costly to develop and introduces a wide range of scientific, clinical, ethical, and socioeconomic issues. PPM raises a multitude of economic issues, including how information on accurate diagnosis and treatment success will be disseminated and who will bear the cost; changes to physician training to incorporate genetics, probability and statistics, and economic considerations; questions about whether the benefits of PPM will be confined to developed countries or will diffuse to emerging economies with less developed health care systems; the effects of patient heterogeneity on cost-effectiveness analysis; and opportunities for PPM's growth beyond treatment of acute illness, such as prevention and reversal of chronic conditions.
 
This volume explores the intersection of the scientific, clinical, and economic factors affecting the development of PPM, including its effects on the drug pipeline, on reimbursement of PPM diagnostics and treatments, and on funding of the requisite underlying research; and it examines recent empirical applications of PPM.   
 

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Economic Dimensions of Personalized and Precision Medicine by Ernst R. Berndt, Dana P. Goldman, John Rowe, Ernst R. Berndt,Dana P. Goldman,John Rowe in PDF and/or ePUB format, as well as other popular books in Negocios y empresa & Negocios en general. We have over one million books available in our catalogue for you to explore.

Table of contents

  1. Cover
  2. Copyright
  3. Title Page
  4. National Bureau of Economic Research
  5. Relation of the Directors to the Work and Publications of the National Bureau of Economic Research
  6. Contents
  7. Acknowledgment
  8. Introduction
  9. 1. The Economic Value and Pricing of Personalized Medicine
  10. 2. Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS
  11. 3. The Value of Pharmacogenomic Information
  12. 4. The Information Pharms Race and Competitive Dynamics of Precision Medicine: Insights from Game Theory
  13. 5. Characterizing the Drug Development Pipeline for Precision Medicines
  14. 6. Cost Sharing in Insurance Coverage for Precision Medicine
  15. 7. Measuring the Potential Health Impact of Personalized Medicine: Evidence from Multiple Sclerosis Treatments
  16. 8. Physicians’ Financial Incentives to Personalize Medicine
  17. 9. Economic Dimensions of Personalized and Precision Medicine in Asia: Evidence from Breast Cancer Treatment in Taiwan
  18. 10. The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy Following a Major Cardiovascular Event: Evidence from Geisinger
  19. 11. Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies
  20. Notes
  21. Contributors
  22. Author Index
  23. Subject Index